Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics of causal relationships between circulating inflammatory proteins and postherpetic neuralgia: a bidirectional Mendelian randomization study. | Front Neurol | 2024 | 38974683 | PubTator, text mining | PubMed |
| Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. | Signal Transduct Target Ther | 2024 | 38945949 | PubTator, text mining | PubMed |
| Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan's National Database. | Genes (Basel) | 2024 | 38927728 | PubTator, text mining | PubMed |
| Latest Advances in Chondrocyte-Based Cartilage Repair. | Biomedicines | 2024 | 38927573 | PubTator, text mining | PubMed |
| Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family. | Mil Med Res | 2024 | 38902808 | PubTator, text mining | PubMed |
| Effects of circulating inflammatory proteins on spinal degenerative diseases: Evidence from genetic correlations and Mendelian randomization study. | JOR Spine | 2024 | 38895179 | PubTator, text mining | PubMed |
| A Search for New Biological Pathways in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy by Proteomic Research. | J Clin Med | 2024 | 38892848 | PubTator, text mining | PubMed |
| Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)-A Randomized Pilot Trial. | Nutrients | 2024 | 38892505 | PubTator, text mining | PubMed |
| The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review. | J ASEAN Fed Endocr Soc | 2024 | 38863907 | PubTator, text mining | PubMed |
| Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis. | PLoS One | 2024 | 38848397 | PubTator, text mining | PubMed |
| Impact of Elevated Fibroblast Growth Factor 23 (FGF23) on the Cardiovascular System: A Comprehensive Systematic Literature Review. | Cureus | 2024 | 38846254 | PubTator, text mining | PubMed |
| Partial liver resection alters the bile salt-FGF19 axis in patients with perihilar cholangiocarcinoma: Implications for liver regeneration. | Hepatol Commun | 2024 | 38836805 | PubTator, text mining | PubMed |
| The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis? | Pharmacol Ther | 2024 | 38795981 | PubTator, text mining | PubMed |
| Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy. | Hepatol Commun | 2024 | 38780301 | PubTator, text mining | PubMed |
| Discovery of 2,6-Naphthyridine Analogues as Selective FGFR4 Inhibitors for Hepatocellular Carcinoma. | J Med Chem | 2024 | 38706130 | PubTator, text mining | PubMed |
| Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials. | Clin Res Hepatol Gastroenterol | 2024 | 38688423 | PubTator, text mining | PubMed |
| Age-Dependent Differences in Postprandial Bile-Acid Metabolism and the Role of the Gut Microbiome. | Microorganisms | 2024 | 38674708 | PubTator, text mining | PubMed |
| [Bile Acid Diarrhea]. | Korean J Gastroenterol | 2024 | 38659249 | PubTator, text mining | PubMed |
| Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients. | Front Cell Infect Microbiol | 2024 | 38650735 | PubTator, text mining | PubMed |
| New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38642480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=16